Giovanni Cagnotto
1 – 10 of 20
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Tumor necrosis factor (TNF) inhibitors for psoriatic arthritis
(
- Contribution to journal › Article
-
Mark
Tumor necrosis factor (TNF) inhibitors for juvenile idiopathic arthritis
(
- Contribution to journal › Scientific review
- 2024
-
Mark
Predictors at diagnosis for start of biologic disease-modifying antirheumatic drugs in patients with early rheumatoid arthritis : a cohort study
(
- Contribution to journal › Article
- 2023
-
Mark
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis : 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial
(
- Contribution to journal › Article
- 2022
-
Mark
Male Sex Predicts a Favorable Outcome in Early ACPA-negative Rheumatoid Arthritis: Data From An Observational Study.
(
- Contribution to journal › Article
-
Mark
COVID-19 vaccination in autoimmune disease (COVAD) survey protocol
(
- Contribution to journal › Article
-
Mark
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies
(
- Contribution to journal › Article
-
Mark
Vaccine hesitancy in patients with autoimmune diseases : Data from the coronavirus disease-2019 vaccination in autoimmune diseases study
(
- Contribution to journal › Letter
- 2020
-
Mark
Active conventional treatment and three different biological treatments in early rheumatoid arthritis : Phase IV investigator initiated, randomised, observer blinded clinical trial
(
- Contribution to journal › Article
-
Mark
TNF-alpha inhibitors for juvenile idiopathic arthritis
(
- Contribution to journal › Scientific review